Atrasentan
Showing 1 - 20 of 20
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
- (no location specified)
Apr 27, 2023
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome Trial in Worldwide (Atrasentan)
Recruiting
- IgA Nephropathy
- +5 more
- Atrasentan
-
Huntsville, Alabama
- +37 more
Dec 1, 2022
IgA Nephropathy, Immunoglobulin A Nephropathy Trial in Worldwide (Atrasentan, Placebo)
Recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
-
Birmingham, Alabama
- +119 more
Aug 17, 2022
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Chronic Kidney Disease, Diabetic Nephropathy Trial in Puerto Rico, United States (Placebo for Atrasentan 0.2 mg/mL solution,
Completed
- Chronic Kidney Disease
- Diabetic Nephropathy
- Placebo for Atrasentan 0.2 mg/mL solution
- +3 more
-
Tempe, Arizona
- +27 more
Jun 1, 2018
Chronic Kidney Disease, Diabetic Nephropathy Trial in Japan (Atrasentan low dose group, Atrasentan high dose group, Atrasentan
Completed
- Chronic Kidney Disease
- Diabetic Nephropathy
- Atrasentan low dose group
- +2 more
-
Azumino, Japan
- +17 more
Aug 25, 2017
Chronic Kidney Disease, Diabetic Nephropathy Trial in United States (Atrasentan, Placebo)
Completed
- Chronic Kidney Disease
- Diabetic Nephropathy
- Atrasentan
- Placebo
-
Phoenix, Arizona
- +27 more
Sep 25, 2013
Chronic Kidney Disease, Diabetic Nephropathy Trial in Worldwide (Atrasentan, Placebo)
Completed
- Chronic Kidney Disease
- Diabetic Nephropathy
- Atrasentan
- Placebo
-
Pell City, Alabama
- +71 more
Aug 20, 2013
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in United States (atrasentan HCl, doxil)
Terminated
- Fallopian Tube Cancer
- +2 more
- atrasentan hydrochloride
- doxil
-
Macon, Georgia
- +5 more
May 16, 2012
Prostate Cancer Trial in Los Angeles (atrasentan HCl)
Completed
- Prostate Cancer
- atrasentan hydrochloride
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Feb 18, 2011
Prostate Cancer, Adenocarcinoma of the Prostate Trial in Boston (Atrasentan, Zoledronic Acid (Zometa))
Completed
- Prostate Cancer
- Adenocarcinoma of the Prostate
- Atrasentan
- Zoledronic Acid (Zometa)
-
Boston, Massachusetts
- +1 more
May 7, 2010
Endothelial Dysfunction Trial in Rochester (Atrasentan, atrasentan)
Completed
- Endothelial Dysfunction
- Atrasentan
- atrasentan
-
Rochester, MinnesotaMayo Clinic
Apr 28, 2010
Kidney Cancer Trial in United States (atrasentan HCl)
Completed
- Kidney Cancer
- atrasentan hydrochloride
-
Scottsdale, Arizona
- +176 more
Jan 26, 2010
Brain and CNS Tumors Trial in United States (atrasentan HCl)
Completed
- Brain and Central Nervous System Tumors
- atrasentan hydrochloride
-
Birmingham, Alabama
- +9 more
Jan 10, 2009
Prostate Cancer, Adenocarcinoma Trial in Worldwide (Atrasentan)
Completed
- Prostate Cancer
- Adenocarcinoma
- Atrasentan
-
Marina Del Rey, California
- +14 more
Nov 28, 2007
Prostatic Tumors Trial in Worldwide (Atrasentan)
Completed
- Prostatic Neoplasms
- Atrasentan
-
Homewood,, Alabama
- +233 more
Aug 13, 2007
Prostatic Tumors Trial in Canada, United States (Atrasentan)
Completed
- Prostatic Neoplasms
- Atrasentan
-
Homewood,, Alabama
- +40 more
Aug 10, 2006
Prostate Cancer Trial in Worldwide (Atrasentan)
Completed
- Prostate Cancer
- Atrasentan
-
Homewood,, Alabama
- +232 more
Aug 10, 2006